Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05363527 · ClinicalTrials.gov registry record · Phase 1
Aging and Reward System Response to Inflammation and Anxiety Study
A Phase 1 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT05363527 is a Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 40 participants.
The verdict
NCT05363527, a Phase 1 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to use an experimental inflammatory challenge to examine whether older adults with symptoms of anxiety experience loss of pleasure or loss of motivation when they are exposed to inflammation. Loss of pleasure or loss of motivation will be evaluated using self-report questionnaires, computer tasks, and during a brain scan.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Endotoxin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2025-12-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05363527
The ClinicalTrials.gov registry entry for NCT05363527 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05363527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05363527 about?
NCT05363527 is a clinical study titled "Aging and Reward System Response to Inflammation and Anxiety Study". The purpose of this study is to use an experimental inflammatory challenge to examine whether older adults with symptoms of anxiety experience loss of pleasure or loss of motivation when they are exposed to inflammation. Loss of pleasure or loss of motivation will be evaluated using self-report ques...
What is the current status of trial NCT05363527?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2023-03-29. Estimated completion is 2025-12-08.
What interventions are being tested in trial NCT05363527?
The interventions under investigation include: Placebo (BIOLOGICAL), Endotoxin (BIOLOGICAL).
Who is sponsoring clinical trial NCT05363527?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.